We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GPhA OPPOSES AUTHORIZED GENERICS, SAYS THEY DEVALUE EXCLUSIVITY
GPhA OPPOSES AUTHORIZED GENERICS, SAYS THEY DEVALUE EXCLUSIVITY
March 5, 2004
The Generic Pharmaceutical Association (GPhA) has come out against the practice of generic firms cutting deals with brand firms to market authorized versions of their products — a practice the trade group contends devalues the 180-day exclusivity provision in the federal drug patent law.